Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $495.59 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $172.45 | 8 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $105.33 | 5 | $0 (2019) |
| GRT US Holding, Inc. | $61.99 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $55.34 | 3 | $0 (2022) |
| Daiichi Sankyo Inc. | $51.59 | 3 | $0 (2017) |
| Medtronic USA, Inc. | $17.70 | 1 | $0 (2017) |
| Collegium Pharmaceutical, Inc. | $17.03 | 1 | $0 (2017) |
| Philips Electronics North America Corporation | $14.16 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.29 | 4 | ABBVIE INC. ($84.29) |
| 2023 | $85.11 | 4 | ABBVIE INC. ($70.95) |
| 2022 | $96.73 | 3 | GRT US Holding, Inc. ($61.99) |
| 2019 | $81.21 | 4 | Avanir Pharmaceuticals, Inc. ($63.01) |
| 2018 | $42.32 | 2 | Avanir Pharmaceuticals, Inc. ($42.32) |
| 2017 | $105.93 | 6 | Daiichi Sankyo Inc. ($51.59) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Medical Device | ||||||
| 10/31/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/18/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/04/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/30/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $61.99 | General |
| Category: Pain Management | ||||||
| 03/28/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/08/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: PSYCHIATRY | ||||||
| 02/11/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 01/03/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 12/07/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: pseudobulbar affect PBA | ||||||
| 11/14/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: pseudobulbar affect PBA | ||||||
| 10/31/2017 | Collegium Pharmaceutical, Inc. | Xtampza ER (Drug) | Food and Beverage | Cash or cash equivalent | $17.03 | General |
| Category: Opioid Analgesic | ||||||
| 07/26/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Opioid Induced Constipation | ||||||
| 06/06/2017 | Medtronic USA, Inc. | ACTIVA (Device) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 05/23/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: PSYCHIATRY | ||||||
| 03/24/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Opioid Induced Constipation | ||||||
| 02/24/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Opioid Induced Constipation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 24 | 31 | $5,427 | $1,891 |
| 2022 | 2 | 27 | 43 | $5,094 | $2,004 |
| 2021 | 2 | 46 | 82 | $8,997 | $3,041 |
| 2020 | 4 | 83 | 169 | $17,545 | $4,651 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 16 | $3,312 | $1,248 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 15 | $2,115 | $642.72 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 26 | $3,666 | $1,459 | 39.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 17 | $1,428 | $544.33 | 38.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 37 | $5,217 | $1,891 | 36.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 45 | $3,780 | $1,150 | 30.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 48 | $6,768 | $2,005 | 29.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 28 | 79 | $6,636 | $1,469 | 22.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 13 | $2,691 | $942.61 | 35.0% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 13 | 29 | $1,450 | $233.86 | 16.1% |
About Howard Katz
Howard Katz is a Rehabilitation Practitioner healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699756320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Howard Katz has received a total of $495.59 in payments from pharmaceutical and medical device companies, with $84.29 received in 2024. These payments were reported across 23 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($495.59).
As a Medicare-enrolled provider, Katz has provided services to 180 Medicare beneficiaries, totaling 325 services with total Medicare billing of $11,586. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Rehabilitation Practitioner
- Location Jackson, MS
- Active Since 11/09/2005
- Last Updated 07/17/2015
- Taxonomy Code 225400000X
- Entity Type Individual
- NPI Number 1699756320
Products in Payments
- BOTOX (Biological) $172.45
- NUEDEXTA (Drug) $105.33
- Qutenza (Drug) $61.99
- Movantik (Drug) $51.59
- REXULTI (Drug) $37.81
- ACTIVA (Device) $17.70
- ABILIFY MAINTENA (Drug) $17.53
- Xtampza ER (Drug) $17.03
- (8874) inCourage (Device) $14.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rehabilitation Practitioner Doctors in Jackson
Dr. Jirapun Laiprasert, M.d, M.D
Rehabilitation Practitioner
Balasubramaniyam Pisupati, Rpt, RPT
Rehabilitation Practitioner
Kyle Justin
Rehabilitation Practitioner
Dr. Stacie Nwabueze, Phd, PHD
Rehabilitation Practitioner
David Sprunger
Rehabilitation Practitioner
Carmen Mitchell
Rehabilitation Practitioner